| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
71,647.38 | 71,647.38 | 98,133.65 | 102,106.51 | 74,817.21 |
| Cost of Revenue
|
-70,739.40 | -70,739.40 | -95,725.71 | -100,190.53 | -73,703.89 |
|
Gross Profit
|
907.98 | 907.98 | 2,407.94 | 1,915.98 | 1,113.32 |
|
Selling, General and Administrative Expenses
|
-2,751.74 | -2,751.74 | -1,422.36 | -828.32 | -746.17 |
| Provision Expense/Write-Back
|
1,400.54 | 1,400.54 | -5,740.37 | 0 | -- |
|
Operating Income/Expenses
|
-1,351.20 | -1,351.20 | -7,162.73 | -828.32 | -746.17 |
|
Total Operating Profit/Loss
|
-443.21 | -443.21 | -4,754.80 | 1,087.65 | 367.15 |
| Total Net Finance Income/Expense
|
-729.91 | -729.91 | 8.69 | 1.20 | 0.13 |
| Net Investment Income
|
-7.78 | -7.78 | -4.80 | -3.18 | -2.30 |
|
Other Income/Expense, Non-Operating
|
0.62 | 0.62 | 1.33 | 9.79 | 32.70 |
|
Non-Operating Income/Expenses, Total
|
-737.06 | -737.06 | 5.21 | 7.81 | 30.53 |
|
Pretax Income
|
-1,180.28 | -1,180.28 | -4,749.58 | 1,095.46 | 397.67 |
|
Provision for Income Tax
|
0 | 0 | -227.14 | -159.34 | -6.56 |
|
Net Income from Continuing Operations
|
-1,180.28 | -1,180.28 | -4,976.72 | 936.12 | 391.11 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,180.28 | -1,180.28 | -4,976.72 | 936.12 | 391.11 |
|
Net Income after Non-Controlling/Minority Interests
|
-1,180.28 | -1,180.28 | -4,976.72 | 936.12 | 391.11 |
|
Net Income Available to Common Stockholders
|
-1,180.28 | -1,180.28 | -4,976.72 | 936.12 | 391.11 |
|
Diluted Net Income Available to Common Stockholders
|
-1,180.28 | -1,180.28 | -4,976.72 | 936.12 | 391.11 |
| Basic EPS
|
-2.80 | -2.80 | -34.48 | 5.99 | 2.50 |
| Diluted EPS
|
-2.80 | -2.80 | -34.48 | 5.99 | 2.50 |
|
Basic Weighted Average Shares Outstanding
|
302.68 | 302.68 | 144.34 | 156.25 | 156.25 |
|
Diluted Weighted Average Shares Outstanding
|
302.68 | 302.68 | 144.34 | 156.25 | 156.25 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-450.37 | -450.37 | -4,758.27 | 1,094.26 | 397.55 |
|
EBITDA
|
-450.37 | -450.37 | -4,758.27 | 1,094.26 | 397.55 |
|
Normalized EBITDA
|
490.85 | 490.85 | -4,758.27 | 1,094.26 | 397.55 |
|
Normalized Income
|
-239.05 | -239.05 | -4,976.72 | 936.12 | 391.11 |
|
Total Unusual Items
|
941.22 | 941.22 | 0 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
941.22 | 941.22 | 0 | 0 | 0 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
12/31/2022 - 10/16/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade